GSA CAPITAL PARTNERS LLP

Position in TNYA — Tenaya Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in TNYA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,972,415

+$1,229,961 QoQ

Shares Held

2,669,033

+148.8% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

of 101 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. TNYA ranks #9 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,972,415	2,669,033	+148.8%	Shares	Sole	2026-08-06
2026-03-31	$742,454	1,072,911	-27.4%	Shares	Sole	2026-05-08
2025-12-31	$1,052,771	1,478,612	+220.2%	Shares	Sole	2026-02-06
2025-09-30	$748,122	461,804	+212.2%	Shares	Sole	2025-11-07
2024-09-30	$285,508	147,932	-18.7%	Shares	Sole	2024-11-05
2024-06-30	$564,392	182,062	-18.7%	Shares	Sole	2024-08-15
2024-03-31	$1,171,786	224,051	-52.4%	Shares	Sole	2024-05-03
2023-12-31	$1,525,537	470,845	+29.5%	Shares	Sole	2024-02-16
2023-09-30	$926,907	363,493	+194.5%	Shares	Sole	2023-11-15
2023-06-30	$724,422	123,411	+40.0%	Shares	Sole	2023-08-14
2023-03-31	$251,278	88,168	+40.7%	Shares	Sole	2023-05-12
2022-09-30	$181,731	62,666	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.